Bruce D. Jackson
Stock Analyst at Benchmark
(3.00)
# 1,489
Out of 5,090 analysts
9
Total ratings
100%
Success rate
37.98%
Average return
Main Sectors:
Stocks Rated by Bruce D. Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Downgrades: Hold | n/a | $101.06 | - | 2 | Nov 24, 2025 | |
| MLSS Milestone Scientific | Maintains: Speculative Buy | $1.25 → $1 | $0.35 | +182.49% | 1 | Nov 20, 2025 | |
| HUMA Humacyte | Maintains: Buy | $14 → $11 | $1.23 | +794.31% | 1 | Nov 13, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $80 → $132 | $150.00 | -12.00% | 1 | Oct 31, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Speculative Buy | $14 → $7 | $0.62 | +1,036.18% | 1 | Sep 15, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Speculative Buy | $3 → $21 | $6.23 | +237.08% | 1 | Sep 15, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $3 → $2 | $0.76 | +163.96% | 1 | Sep 10, 2025 | |
| CLNN Clene | Maintains: Buy | $33 → $31 | $5.77 | +437.26% | 1 | Sep 10, 2025 |
Exact Sciences
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $101.06
Upside: -
Milestone Scientific
Nov 20, 2025
Maintains: Speculative Buy
Price Target: $1.25 → $1
Current: $0.35
Upside: +182.49%
Humacyte
Nov 13, 2025
Maintains: Buy
Price Target: $14 → $11
Current: $1.23
Upside: +794.31%
Belite Bio
Oct 31, 2025
Maintains: Buy
Price Target: $80 → $132
Current: $150.00
Upside: -12.00%
Reviva Pharmaceuticals Holdings
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $14 → $7
Current: $0.62
Upside: +1,036.18%
Unicycive Therapeutics
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $3 → $21
Current: $6.23
Upside: +237.08%
Harvard Bioscience
Sep 10, 2025
Maintains: Speculative Buy
Price Target: $3 → $2
Current: $0.76
Upside: +163.96%
Clene
Sep 10, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $5.77
Upside: +437.26%